Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

This study is currently recruiting participants.

Verified July 2011 by University of Nebraska

First Received on October 28, 2009. Last Updated on July 6, 2011 History of Changes

Sponsor:	University of Nebraska
Information provided by:	University of Nebraska
ClinicalTrials.gov Identifier:	NCT01007357

Purpose

This project will facilitate the optimization of body MR imaging at 3 Tesla.

Condition	Intervention
Diffuse and Focal Abnormalities of the Liver and Pancreas	Device: optimize MRI sequences

Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic
Official Title:	Abdominal MR Imaging at 3.0T: Sequence Optimization and Implementation

Further study details as provided by University of Nebraska:

Primary Outcome Measures:

to optimize body MR imaging sequences [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Estimated Enrollment:	120
Study Start Date:	December 2009
Estimated Study Completion Date:	September 2012
Estimated Primary Completion Date:	September 2012 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
No Intervention: healthy volunteers Body MR imaging will be performed to optimize sequences	Device: optimize MRI sequences optimize MRI sequences Other Name: optimize MRI sequences
No Intervention: Disorder subjects Optimized sequences will be used for subjects enrolled in the study who are scheduled for a MRI by their referring physician.	Device: optimize MRI sequences optimize MRI sequences Other Name: optimize MRI sequences

Eligibility

Criteria

Inclusion Criteria:

Subjects between ages of 19 and 65
Healthy volunteer subjects should not have any history of disease or symptoms - based on clinical history
Subjects with an underlying disorder (diffuse and focal abnormalities of the liver and pancreas)

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT01007357

Contacts

Contact: Shahid Hussain, MD

402-559-1010

Locations

United States, Nebraska
University of Nebraska Medical Center	Not yet recruiting
Omaha, Nebraska, United States, 68198-1045
Contact: Shahid Hussain, MD 402-559-1010 smhussain@unmc.edu
University of Nebraska Medical Center	Recruiting
Omaha, Nebraska, United States, 68198
Contact: Shahid Hussain, MD 402-559-1010 smhussan@unmc.edu
Contact: Marie Witthoft 402-559-4828 mwitthof@unmc.edu

Sponsors and Collaborators

University of Nebraska

Investigators

Principal Investigator:

Shahid Hussain, MD

University of Nebraska

More Information

No publications provided

Responsible Party:	Shahid Hussain, MD, Professor
ClinicalTrials.gov Identifier:	NCT01007357 History of Changes
Other Study ID Numbers:	290-09
Study First Received:	October 28, 2009
Last Updated:	July 6, 2011
Health Authority:	United States: Institutional Review Board

Additional relevant MeSH terms:

Congenital Abnormalities

ClinicalTrials.gov processed this record on February 09, 2012